Quarterly report pursuant to Section 13 or 15(d)

10. SEGMENTS (Tables)

v3.20.1
10. SEGMENTS (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Summarized segment financial information
Three Months Ended March 31, 2020
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 7,743,275     $ 2,420,761     $ 35,708     $ 10,199,744  
                                 
Cost of product revenue     14,451,954       2,377,272       —         16,829,226  
                                 
Loss from operations     (12,476,144 )     (457,155 )     (3,836,487 )     (16,769,786 )
                                 
Interest and other expense, net     (238,873 )     —         (2,236,571 )     (2,475,444 )
                                 
Net loss     (12,715,017 )     (457,155 )     (6,073,058 )     (19,245,230 )
                                 
Capital expenditures     1,914,614       160,262       —         2,074,876  
                                 
Depreciation and amortization expense     674,973       111,289       2,576       788,838  
                                 
Total assets     104,645,897       5,376,807       100,501,123       210,523,827  

 

Three Months Ended March 31, 2019
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 1,343,983     $ 2,148,898     $ 35,708     $ 3,528,589  
                                 
Cost of product revenue     7,940,346       1,464,833       —         9,405,179  
                                 
(Loss) income from operations     (10,620,807 )     29,579       (2,617,188 )     (13,208,416 )
                                 
Interest and other (expense) income, net     (169,613 )     13,620       (1,268,472 )     (1,424,465 )
                                 
Gain on transfer of plasma center assets     —         11,527,421       —         11,527,421  
                                 
Loss on extinguishment of debt     —         —         (9,962,495 )     (9,962,495 )
                                 
Net (loss) income     (10,790,420 )     11,570,620       (13,848,155 )     (13,067,955 )
                                 
Capital expenditures     110,453       —         —         110,453  
                                 
Depreciation and amortization expense     687,393       114,241       3,696       805,330  
                                 
Total assets     57,529,070       4,038,367       16,552,533       78,119,970